La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Jardine Cycle & Carriage Croissance future
Future contrôle des critères 0/6
Jardine Cycle & Carriage devrait augmenter ses bénéfices et son chiffre d'affaires de 1.7% et de 2.9% par an respectivement. Le BPA devrait croître de de 3.8% par an. Le rendement des capitaux propres devrait être 12.3% dans 3 ans.
Informations clés
1.7%
Taux de croissance des bénéfices
3.8%
Taux de croissance du BPA
Industrials croissance des bénéfices | 14.1% |
Taux de croissance des recettes | 2.9% |
Rendement futur des capitaux propres | 12.3% |
Couverture par les analystes | Low |
Dernière mise à jour | 19 Aug 2024 |
Mises à jour récentes de la croissance future
Recent updates
Jardine Cycle & Carriage (SGX:C07) Seems To Use Debt Quite Sensibly
Jun 24A Look At The Intrinsic Value Of Jardine Cycle & Carriage Limited (SGX:C07)
May 23Returns Are Gaining Momentum At Jardine Cycle & Carriage (SGX:C07)
May 07Most Shareholders Will Probably Agree With Jardine Cycle & Carriage Limited's (SGX:C07) CEO Compensation
Apr 22The Returns At Jardine Cycle & Carriage (SGX:C07) Aren't Growing
Jan 19Jardine Cycle & Carriage Limited (SGX:C07) Could Be Riskier Than It Looks
Dec 27Jardine Cycle & Carriage (SGX:C07) Has A Pretty Healthy Balance Sheet
Oct 31Estimating The Intrinsic Value Of Jardine Cycle & Carriage Limited (SGX:C07)
Oct 09Returns At Jardine Cycle & Carriage (SGX:C07) Appear To Be Weighed Down
Sep 21Jardine Cycle & Carriage Limited's (SGX:C07) Intrinsic Value Is Potentially 24% Below Its Share Price
Jul 08Is Jardine Cycle & Carriage (SGX:C07) Using Too Much Debt?
Jun 16The Returns At Jardine Cycle & Carriage (SGX:C07) Aren't Growing
May 29Does Jardine Cycle & Carriage (SGX:C07) Have A Healthy Balance Sheet?
Mar 16Calculating The Intrinsic Value Of Jardine Cycle & Carriage Limited (SGX:C07)
Feb 27Jardine Cycle & Carriage's (SGX:C07) Returns Have Hit A Wall
Jan 23An Intrinsic Calculation For Jardine Cycle & Carriage Limited (SGX:C07) Suggests It's 32% Undervalued
Nov 12Here's What To Make Of Jardine Cycle & Carriage's (SGX:C07) Decelerating Rates Of Return
Oct 25Jardine Cycle & Carriage (SGX:C07) Has A Rock Solid Balance Sheet
Oct 04Some Investors May Be Worried About Jardine Cycle & Carriage's (SGX:C07) Returns On Capital
Jul 19Jardine Cycle & Carriage (SGX:C07) Seems To Use Debt Quite Sensibly
Jun 22There Are Reasons To Feel Uneasy About Jardine Cycle & Carriage's (SGX:C07) Returns On Capital
Apr 01Here's Why Jardine Cycle & Carriage (SGX:C07) Can Manage Its Debt Responsibly
Mar 17When Should You Buy Jardine Cycle & Carriage Limited (SGX:C07)?
Jan 05Returns On Capital At Jardine Cycle & Carriage (SGX:C07) Have Hit The Brakes
Dec 18These 4 Measures Indicate That Jardine Cycle & Carriage (SGX:C07) Is Using Debt Reasonably Well
Nov 03An Intrinsic Calculation For Jardine Cycle & Carriage Limited (SGX:C07) Suggests It's 25% Undervalued
Oct 13When Should You Buy Jardine Cycle & Carriage Limited (SGX:C07)?
Sep 28Returns On Capital At Jardine Cycle & Carriage (SGX:C07) Have Stalled
Sep 09Jardine Cycle & Carriage's (SGX:C07) Soft Earnings Don't Show The Whole Picture
Aug 05Here's Why Jardine Cycle & Carriage (SGX:C07) Can Manage Its Debt Responsibly
Jul 30Are Investors Undervaluing Jardine Cycle & Carriage Limited (SGX:C07) By 21%?
Jun 25Investors Met With Slowing Returns on Capital At Jardine Cycle & Carriage (SGX:C07)
Jun 11These 4 Measures Indicate That Jardine Cycle & Carriage (SGX:C07) Is Using Debt Extensively
Mar 01Is It Time To Consider Buying Jardine Cycle & Carriage Limited (SGX:C07)?
Feb 15Reflecting on Jardine Cycle & Carriage's (SGX:C07) Share Price Returns Over The Last Three Years
Jan 23Is Jardine Cycle & Carriage Limited (SGX:C07) Worth S$19.9 Based On Its Intrinsic Value?
Jan 05Here's What To Make Of Jardine Cycle & Carriage's (SGX:C07) Returns On Capital
Dec 21Key Things To Watch Out For If You Are After Jardine Cycle & Carriage Limited's (SGX:C07) 5.7% Dividend
Dec 06Has Jardine Cycle & Carriage Limited's (SGX:C07) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Nov 20Prévisions de croissance des bénéfices et des revenus
Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
---|---|---|---|---|---|
12/31/2026 | 22,800 | 1,095 | 738 | 2,019 | 4 |
12/31/2025 | 22,313 | 1,022 | 846 | 2,014 | 5 |
12/31/2024 | 21,360 | 985 | 1,155 | 2,239 | 5 |
6/30/2024 | 21,362 | 1,050 | 1,512 | 2,789 | N/A |
3/31/2024 | 21,798 | 1,133 | 1,225 | 2,630 | N/A |
12/31/2023 | 22,235 | 1,215 | 938 | 2,471 | N/A |
9/30/2023 | 22,302 | 1,058 | 1,271 | 2,693 | N/A |
6/30/2023 | 22,470 | 901 | 1,604 | 2,915 | N/A |
3/31/2023 | 22,018 | 820 | 1,786 | 2,883 | N/A |
12/31/2022 | 21,566 | 740 | 1,967 | 2,851 | N/A |
9/30/2022 | 20,824 | 831 | 2,260 | 3,034 | N/A |
6/30/2022 | 20,082 | 922 | 2,552 | 3,218 | N/A |
3/31/2022 | 18,885 | 791 | 2,541 | 3,123 | N/A |
12/31/2021 | 17,688 | 661 | 2,529 | 3,028 | N/A |
9/30/2021 | 16,307 | 563 | 2,765 | 3,217 | N/A |
6/30/2021 | 14,927 | 466 | 3,001 | 3,405 | N/A |
3/31/2021 | 14,080 | 503 | 2,657 | 3,080 | N/A |
12/31/2020 | 13,234 | 540 | 2,314 | 2,754 | N/A |
9/30/2020 | 14,597 | 573 | 1,583 | 2,146 | N/A |
6/30/2020 | 16,029 | 755 | 1,236 | 1,920 | N/A |
3/31/2020 | 17,172 | 719 | 953 | 1,764 | N/A |
12/31/2019 | 18,591 | 881 | 677 | 1,712 | N/A |
9/30/2019 | 18,917 | 773 | 1,202 | 2,287 | N/A |
6/30/2019 | 18,960 | 672 | 1,499 | 2,648 | N/A |
3/31/2019 | 19,065 | 597 | 856 | 1,978 | N/A |
12/31/2018 | 18,992 | 418 | 1,560 | 2,614 | N/A |
9/30/2018 | 18,593 | 708 | 1,140 | 2,196 | N/A |
6/30/2018 | 18,172 | 713 | 509 | 1,454 | N/A |
3/31/2018 | 17,831 | 862 | N/A | 1,746 | N/A |
12/31/2017 | 17,337 | 939 | N/A | 1,655 | N/A |
9/30/2017 | 16,859 | 793 | N/A | 1,413 | N/A |
6/30/2017 | 16,414 | 773 | N/A | 1,621 | N/A |
3/31/2017 | 16,264 | 773 | N/A | 1,335 | N/A |
12/31/2016 | 15,764 | 702 | N/A | 1,417 | N/A |
9/30/2016 | 15,414 | 665 | N/A | 1,527 | N/A |
6/30/2016 | 15,184 | 659 | N/A | 1,599 | N/A |
3/31/2016 | 15,348 | 655 | N/A | 1,599 | N/A |
12/31/2015 | 15,718 | 691 | N/A | 1,848 | N/A |
9/30/2015 | 16,499 | 714 | N/A | 1,805 | N/A |
6/30/2015 | 17,410 | 746 | N/A | 1,516 | N/A |
3/31/2015 | 18,023 | 779 | N/A | 1,669 | N/A |
12/31/2014 | 18,675 | 820 | N/A | 1,240 | N/A |
9/30/2014 | 18,854 | 887 | N/A | 1,227 | N/A |
6/30/2014 | 18,887 | 896 | N/A | 1,599 | N/A |
3/31/2014 | 19,247 | 902 | N/A | 1,530 | N/A |
12/31/2013 | 19,788 | 915 | N/A | 1,931 | N/A |
9/30/2013 | 20,041 | 827 | N/A | 1,783 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de C07 ( 1.7% par an) est inférieure au taux d'épargne ( 2.2% ).
Bénéfices vs marché: Les bénéfices de C07 ( 1.7% par an) devraient croître plus lentement que le marché SG ( 10.2% par an).
Croissance élevée des bénéfices: Les bénéfices de C07 devraient augmenter, mais pas de manière significative.
Chiffre d'affaires vs marché: Le chiffre d'affaires de C07 ( 2.9% par an) devrait croître plus lentement que le marché de SG ( 3.7% par an).
Croissance élevée des revenus: Le chiffre d'affaires de C07 ( 2.9% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de C07 devrait être faible dans 3 ans ( 12.3 %).